Masayon, Kosephine .
HRN: 25-38-56 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/15/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/15/2024
12/16/2024
IV
500mg
Q8hrs
S/P LSTCS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes